OnCore Login

Return to Trial Database

HCRN-GI14-186

A Multi-Center, Single Arm, Phase II study of Pembrolizumab (MK-3475) in Combination with Chemotherapy for Patients with Advanced Colorectal Cancer: HCRN GI14-186

Status

Study Completed

Cancer Type(s)

Colorectal

Study Contact

Publications

A phase II study of pembrolizumab in combination with mFOLFOX6 for patients with advanced colorectal cancer
  • S Shahda, AM Noonan, TS Bekaii-Saab, BH O'Neil, A Sehdev, W Labib Shaib, PR Helft, PJ Loehrer, Y Tong, Z Liu, BF El-Rayes
A multi-center, single-arm, phase Ib study of pembrolizumab (MK-3475) in combination with chemotherapy for patients with advanced colorectal cancer
  • CJ Herting, MR Farren, Y Tong, Z Liu, B O’Neil, T Bekaii-Saab, A Noonan, C McQuinn, TA Mace, W Shaib, C Wu, BF El-Rayes, S Shahda, GB Lesinski

Trial Locations

All sites in which the trial HCRN-GI14-186 being conducted in.
No data was found
  • 7676 Interactive Way, Suite 120, Indianapolis, IN 46278